169 related articles for article (PubMed ID: 23335599)
1. Low rates of hepatitis C testing among people who inject drugs in Thailand: implications for peer-based interventions.
Ti L; Kaplan K; Hayashi K; Suwannawong P; Wood E; Kerr T
J Public Health (Oxf); 2013 Dec; 35(4):578-84. PubMed ID: 23335599
[TBL] [Abstract][Full Text] [Related]
2. Health and safety risks associated with public injecting among people who inject drugs in Bangkok, Thailand.
Leung LT; Ti L; Hayashi K; Suwannawong P; Kaplan K; Wood E; Kerr T
Drug Alcohol Rev; 2013 Nov; 32(6):582-7. PubMed ID: 24033410
[TBL] [Abstract][Full Text] [Related]
3. Willingness to access peer-delivered HIV testing and counseling among people who inject drugs in Bangkok, Thailand.
Ti L; Hayashi K; Kaplan K; Suwannawong P; Wood E; Montaner J; Kerr T
J Community Health; 2013 Jun; 38(3):427-33. PubMed ID: 23149569
[TBL] [Abstract][Full Text] [Related]
4. Experiences with urine drug testing by police among people who inject drugs in Bangkok, Thailand.
Hayashi K; Ti L; Buxton JA; Kaplan K; Suwannawong P; Wood E; Kerr T
Int J Drug Policy; 2014 Mar; 25(2):297-302. PubMed ID: 24332458
[TBL] [Abstract][Full Text] [Related]
5. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
6. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
Treloar C; Hull P; Dore GJ; Grebely J
Drug Alcohol Rev; 2012 Nov; 31(7):918-24. PubMed ID: 22612899
[TBL] [Abstract][Full Text] [Related]
7. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis C and correlates of seropositivity among men who have sex with men in Vancouver, Canada: a cross-sectional survey.
Wong J; Moore D; Kanters S; Buxton J; Robert W; Gustafson R; Hogg R; Ogunnaike-Cooke S; Wong T; Gilbert M;
Sex Transm Infect; 2015 Sep; 91(6):430-3. PubMed ID: 25872512
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection among people who inject drugs in Bangkok, Thailand, 2005-2010.
Martin M; Vanichseni S; Leelawiwat W; Anekvorapong R; Raengsakulrach B; Cherdtrakulkiat T; Sangkum U; Mock PA; Leethochawalit M; Chiamwongpaet S; McNicholl JM; Kittimunkong S; Curlin ME; Choopanya K;
WHO South East Asia J Public Health; 2019 Apr; 8(1):50-55. PubMed ID: 30950431
[TBL] [Abstract][Full Text] [Related]
10. Expanding the reach of harm reduction in Thailand: experiences with a drug user-run drop-in centre.
Kerr T; Hayashi K; Fairbairn N; Kaplan K; Suwannawong P; Zhang R; Wood E
Int J Drug Policy; 2010 May; 21(3):255-8. PubMed ID: 19766474
[TBL] [Abstract][Full Text] [Related]
11. Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users.
Burt RD; Thiede H; Hagan H
Drug Alcohol Depend; 2009 Dec; 105(3):215-20. PubMed ID: 19720473
[TBL] [Abstract][Full Text] [Related]
12. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.
Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068
[TBL] [Abstract][Full Text] [Related]
13. Healthcare avoidance by people who inject drugs in Bangkok, Thailand.
Heath AJ; Kerr T; Ti L; Kaplan K; Suwannawong P; Wood E; Hayashi K
J Public Health (Oxf); 2016 Sep; 38(3):e301-e308. PubMed ID: 26491067
[TBL] [Abstract][Full Text] [Related]
14. HIV testing and willingness to get HIV testing at a peer-run drop-in centre for people who inject drugs in Bangkok, Thailand.
Ti L; Hayashi K; Kaplan K; Suwannawong P; Fu E; Wood E; Kerr T
BMC Public Health; 2012 Mar; 12():189. PubMed ID: 22414406
[TBL] [Abstract][Full Text] [Related]
15. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
[TBL] [Abstract][Full Text] [Related]
16. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California.
Ozga JE; Syvertsen JL; Pollini RA
J Viral Hepat; 2022 Jul; 29(7):518-528. PubMed ID: 35357738
[TBL] [Abstract][Full Text] [Related]
18. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
[TBL] [Abstract][Full Text] [Related]
19. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.
Palmateer N; Hutchinson S; McAllister G; Munro A; Cameron S; Goldberg D; Taylor A
J Viral Hepat; 2014 Jan; 21(1):25-32. PubMed ID: 24329854
[TBL] [Abstract][Full Text] [Related]
20. Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection.
Artenie AA; Zang G; Daniel M; Fortier E; Jutras-Aswad D; Puzhko S; Bruneau J
Int J Drug Policy; 2017 Sep; 47():239-243. PubMed ID: 28587944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
